Cargando…
Tabla de Contenidos:
  • The Childrenâ€?s Vaccine Initiative: Continuing Activities
  • Copyright
  • Preface
  • Contents
  • Promise and Problems: Hib, Pneumococcal, and Meningococcal Vaccines in the Developing World
  • INTRODUCTION
  • ARI AND MENINGOCOCCAL MENINGITIS IN THE DEVELOPING WORLD
  • DETERMINING VACCINE NEED
  • OVERCOMING SCIENTIFIC AND TECHNOLOGICAL BARRIERS
  • Pneumococcal Vaccines
  • Meningococcal Vaccines
  • PROVING VACCINE EFFICACY: THE CHALLENGE OF DEVELOPING-COUNTRY FIELD TRIALS
  • The Public-/Private-Sector Interface
  • INTRODUCING AN EFFECTIVE VACCINE
  • Involving the U.S. Public and Private Sectors in the CVIINTRODUCTION
  • BRINGING CLARITY TO THE CVI “VISIONâ€?
  • TRENDS IN THE GLOBAL VACCINE SITUATION
  • Industry Characteristics
  • Local Production and Self-Sufficiency
  • RESHAPING THE EPI
  • A ROLE FOR INDUSTRY
  • Barriers to Participation
  • FACILITATING GREATER U.S. INVOLVEMENT
  • Differential Pricing
  • Technology Transfer
  • DISCUSSION SUMMARY
  • Appendix A Promise and Problems: Hib, Pneumococcal, and Meningococcal Vaccines in the Developing World
  • FINAL AGENDA
  • Day 1
  • Day 2
  • WORKSHOP SPEAKERSWORKSHOP PARTICIPANTS
  • Staff
  • Appendix B Involving the U.S. Public and Private Sectors in the CVI
  • FINAL AGENDA
  • Day 1
  • Involving the U.S. Public and Private Sectors in the CVI
  • WORKSHOP SPEAKERS
  • COMMISSIONED PAPER
  • WORKSHOP PARTICIPANTS
  • Staff
  • Appendix C Acronyms and Abbreviations